Article Versions Notes

Poletto S, Paruzzo L, Nepote A, Caravelli D, Sangiolo D, Carnevale-Schianca F. Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective. Cancers. 2024; 16(1):101. https://doi.org/10.3390/cancers16010101

Poletto, Stefano, Luca Paruzzo, Alessandro Nepote, Daniela Caravelli, Dario Sangiolo, and Fabrizio Carnevale-Schianca. 2024. "Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective" Cancers 16, no. 1: 101. https://doi.org/10.3390/cancers16010101

Poletto, S., Paruzzo, L., Nepote, A., Caravelli, D., Sangiolo, D., & Carnevale-Schianca, F. (2024). Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective. Cancers, 16(1), 101. https://doi.org/10.3390/cancers16010101